Literature DB >> 17237983

Isoflurane potency in the northern leopard frog Rana pipiens is similar to that in mammalian species and is unaffected by decerebration.

L S Barter1, L O Mark, A C Smith, J F Antognini.   

Abstract

Amphibians are commonly used in biomedical research, including studies of mechanisms of anaesthetic action. There is, however, little published work describing the kinetics of inhaled anaesthetic agents or the potency of isoflurane in amphibians. Ten Northern leopard frogs were exposed to a constant isoflurane concentration of 1.0%, 1.2% or 1.5% atm for 4 h, and their response to a noxious stimulus was tested every 20 min. Each frog was anaesthetized with each concentration in random order and allowed at least 16 h to recover between anaesthetic exposures. Frogs were then pithed and the protocol was repeated. Frogs first displayed immobility during stimulus application at 80 min, and the proportion of animals becoming immobile steadily increased to reach a stable level at 4 h. The 50% effective dose for isoflurane in intact and pithed frogs did not differ, and was 1.15 and 1.25% atm, respectively. The potency of isoflurane in leopard frogs was similar to that reported in mammalian species. Cutaneous uptake of anaesthetic is effective given sufficient time, approximately 4 h in this study. Forebrain structures appear to be unimportant for the immobilizing action of isoflurane in the frog.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237983     DOI: 10.1007/s11259-007-0077-5

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  19 in total

1.  Quantitative analysis of blood circulation through the frog heart.

Authors:  K T DELONG
Journal:  Science       Date:  1962-11-09       Impact factor: 47.728

2.  Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages.

Authors:  W C Stevens; W M Dolan; R T Gibbons; A White; E I Eger; R D Miller; R H DeJong; R M Elashoff
Journal:  Anesthesiology       Date:  1975-02       Impact factor: 7.892

3.  Isoflurane potency in the dog and cat.

Authors:  E P Steffey; D Howland
Journal:  Am J Vet Res       Date:  1977-11       Impact factor: 1.156

4.  Minimal alveolar concentration (MAC) and dose-response curves in anesthesia.

Authors:  C Y Shim; N B Andersen
Journal:  Anesthesiology       Date:  1972-02       Impact factor: 7.892

5.  The effect of oxygen on minimal anesthetic requirements in the toad.

Authors:  C Y Shim; N B Andersen
Journal:  Anesthesiology       Date:  1971-04       Impact factor: 7.892

6.  Median effective dose of isoflurane, sevoflurane, and desflurane in green iguanas.

Authors:  Linda S Barter; Michelle G Hawkins; Robert J Brosnan; Joseph F Antognini; Bruno H Pypendop
Journal:  Am J Vet Res       Date:  2006-03       Impact factor: 1.156

7.  Scaling of respiratory variables in mammals.

Authors:  W R Stahl
Journal:  J Appl Physiol       Date:  1967-03       Impact factor: 3.531

8.  Respiratory gas transport by the incompletely separated double circulation in the bullfrog, Rana catesbeiana.

Authors:  H Tazawa; M Mochizuki; J Piiper
Journal:  Respir Physiol       Date:  1979-02

9.  Exaggerated anesthetic requirements in the preferentially anesthetized brain.

Authors:  J F Antognini; K Schwartz
Journal:  Anesthesiology       Date:  1993-12       Impact factor: 7.892

10.  Ventilation and partitioning of oxygen uptake in the frog Rana pipiens: effects of hypoxia and activity.

Authors:  A W Pinder; W W Burggren
Journal:  J Exp Biol       Date:  1986-11       Impact factor: 3.312

View more
  2 in total

1.  Kinetics and potency of halothane, isoflurane, and desflurane in the Northern Leopard frog Rana pipiens.

Authors:  L S Barter; J F Antognini
Journal:  Vet Res Commun       Date:  2008-03-20       Impact factor: 2.459

2.  Ectothermy and cardiac shunts profoundly slow the equilibration of inhaled anaesthetics in a multi-compartment model.

Authors:  Catherine J A Williams; Christian Lind Malte; Hans Malte; Mads F Bertelsen; Tobias Wang
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.